Sutter Health study highlights the power and potential of ambient AI to improve clinician well-being
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Sep-2025 05:11 ET (13-Sep-2025 09:11 GMT/UTC)
Researchers at Sutter Health, led by Cheryl Stults, Ph.D., found that an innovative ambient artificial intelligence platform showed promising results in easing the burden of clinical documentation for healthcare providers. The study, published today in JAMA Network Open, revealed significant reductions in documentation time and improved overall clinician satisfaction. It also highlights the technology’s potential to address long-standing challenges in the medical profession.
Many mitochondrial diseases have been difficult to study and treat due to the inherent challenges in accessing mitochondrial DNA (mtDNA). Now, researchers from Japan have optimized mitochondrial-targeted compounds that can selectively modify the ratio of normal versus mutant mtDNA in patient-derived stem cells. This technology enables the creation of research models with varying mutation loads and demonstrates potential as a therapeutic strategy for reducing mutant mtDNA in patients, offering hope for mitochondrial disease treatment.
Frequent heat and drought events in southwestern Europe are reducing ecosystems’ capacity to absorb CO₂, according to a recent study by the Institute of Environmental Science and Technology at the Universitat Autònoma de Barcelona (ICTA-UAB).